Rapport Therapeutics (NASDAQ:RAPP) Shares Down 5.5%
Rapport Therapeutics (NASDAQ:RAPP – Get Free Report) fell 5.5% during trading on Wednesday . The company traded as low as $18.62 and last traded at $18.65. 49,760 shares changed hands during trading, a decline of 69% from the average session volume of 158,172 shares. The stock had previously closed at $19.74. Analysts Set New Price […]
More Stories
Charles River Laboratories International, Inc. (NYSE:CRL) Stock Holdings Trimmed by KBC Group NV
KBC Group NV lowered its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 37.3%...
Plato Investment Management Ltd Has $40,000 Stake in Core & Main, Inc. (NYSE:CNM)
Plato Investment Management Ltd lowered its position in Core & Main, Inc. (NYSE:CNM – Free Report) by 77.6% in the...
Huntington National Bank Boosts Holdings in Schlumberger Limited (NYSE:SLB)
Huntington National Bank increased its position in Schlumberger Limited (NYSE:SLB – Free Report) by 4.4% in the 3rd quarter, according...
Plato Investment Management Ltd Makes New Investment in TFI International Inc. (NYSE:TFII)
Plato Investment Management Ltd purchased a new stake in shares of TFI International Inc. (NYSE:TFII – Free Report) in the...
Huntington National Bank Increases Stake in Moody’s Co. (NYSE:MCO)
Huntington National Bank raised its holdings in shares of Moody’s Co. (NYSE:MCO – Free Report) by 10.5% during the third...
Huntington National Bank Has $826,000 Stake in CBRE Group, Inc. (NYSE:CBRE)
Huntington National Bank boosted its holdings in shares of CBRE Group, Inc. (NYSE:CBRE – Free Report) by 14.5% during the...